|
Catalog #
|
Source:
|
Lot #
|
Size:
|
|
AP2006a
|
Rabbit
|
SH021216L
|
0.1 mg
|
|
Concentration:
|
Accession:
|
Clone Name:
|
Isotype:
|
|
0.25 mg/ml
|
NP_001195, Q13873
|
RB1778
|
Rabbit Ig
|
|
Applications:
|
Reactivity:
|
MW (kDa):
|
|
WB, IHC, E
|
H, M
|
115201 Da
|
|
Target/Specificity:
|
|
This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human BMPR2.
|
|
Other Names:
|
|
Bone morphogenetic protein receptor type-2; Bone morphogenetic protein receptor type II; BMP type II receptor; BMPR-II; PPH1
|
|
Application Data:
|
Western blot analysis of anti-BMPR2 Pab (Cat. #ap2006a) in mouse heart tissue lysate. BMPR2 (arrow) was detected using purified Pab. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. |
Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with BMPR2 antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |
|
|
Background:
|
|
BMPR2 is a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors
bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in BMPR2 have been associated with primary pulmonary hypertension.
|
|
Background References:
|
- Pouliot, F., et al., Cancer Res. 63(2):277-281 (2003).
- Nishihara, A., et al., Mol. Biol. Cell 13(9):3055-3063 (2002).
- Humbert, M., et al., Eur Respir J 20(3):518-523 (2002).
- Vitt, U.A., et al., Biol. Reprod. 67(2):473-480 (2002).
- Nohe, A., et al., J. Biol. Chem. 277(7):5330-5338 (2002).
|
|
Product Citations:
|
- Aquiles Jara, et al. Nephrol. Dial. Transplant., Nov 2008; 10.1093/ndt/gfn611. (Applications: WB)
- Pravin B. Sehgal, et al. Am J Physiol Lung Cell Mol Physiol, Jun 2007; 292: L1526 - L1542. (Applications: WB)
|
|
Application Notes:
|
| The suggested dilution will be: | |
| ELISA | 1:1,000 |
| Western blotting | 1:100~500 |
| Immunohistochemistry | 1:50~100 |
|
|
Format:
|
|
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
|
|
Storage:
|
|
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
|
|
Precautions:
|
|
This product is for research use only. Not for use in diagnostic
or therapeutic procedures.
|